Sunday 22 April 2018 ,
Sunday 22 April 2018 ,
Latest News
  • Court sets May 16 for deposition over Rana Plaza collapse case
  • India cabinet clears ordinance on death penalty to child rapists
  • Govt doing ‘foul politics’ over Khaleda’s treatment: BNP
  • Bangladesh took little steps to prosecute abuses, killings by security forces: US
19 March, 2018 00:00 00 AM

First steps taken for vaccine pills

BBC News Health
First steps taken for vaccine pills

Alex Therrien

UK scientists have taken the first steps towards creating new vaccine treatments in pill form.

The Cardiff team has made a prototype oral flu vaccine, which unlike standard inoculations does not need to be stored in a fridge or freezer.

They hope it could pave the way for needle-free inoculations for lots of different diseases that would be easier to use in developing countries.

However, they said more work was needed before it could be tested in people.

Mimicking infection

Traditional biological vaccines work by introducing a safe form of a virus or bacteria - or a harmless part of it, such as a peptide - in order to provoke an immune response in the body.This allows the body to recognise an illness, such as flu, and deal with it more effectively should it ever encounter it for real.

But the difficulty with these biological vaccines is that they need to be frozen or refrigerated throughout transport to keep them stable, making them costly and difficult to deliver in countries without a reliable electrical supply.

For this new influenza-A vaccine, scientists at Cardiff University created man-made peptides that mimic those in real viruses.

Unlike the biological peptides, these "mirror image" molecules cannot be digested, opening up the possibility for them to be administered in pill form.

The study, published in the Journal of Clinical Investigation, found the prototype triggered a strong immune system response in human cells when tested in a culture dish.

And it was as effective as the standard biological influenza peptide when tested in mice.

It was also shown to generate cells that kill the influenza virus when it was given orally to the mice.

Prof Andrew Sewell, from Cardiff University's school of medicine, who led the study, said: "There are many benefits to oral vaccines.

"Not only would they be great news for people who have a fear of needles but they can also be much easier to store and transport, making them far more suitable for use in remote locations where current vaccine delivery systems can be problematic."

However, researchers acknowledged that much more research was needed to develop these synthetic vaccinations for the entire population and for other diseases.

They added it was likely to take several years before such a vaccine could be tested in people.

'Novel approach'

There is another oral vaccine already in existence - oral polio vaccine - but that needs to be stored in a freezer.

Zania Stamataki, senior lecturer in viral immunology, at the University of Birmingham, said: "This important novel approach to vaccine design could change vaccine development against multiple diseases, particularly those infecting hard-to-reach populations affected by natural disasters or war."

Divya Shah, from the Wellcome Trust's infection and immunobiology team, said the "exciting" study provided "a potential route to make synthetic vaccines that are heat stable and could be taken orally".

"However, much more research is needed to translate the findings into real-world vaccines."

Jonathan Ball, a professor of molecular virology at Nottingham University, said: "It will be important to see if the peptides can still protect against infection when administered by mouth, and equally crucial to see if they work in humans, but it's an exciting first step nonetheless."

 

Comments

Most Viewed
Digital Edition
More story
From the Editor

From the Editor

Parkinson’s disease is a slowly progressing, degenerative disorder of the nervous system; Parkinson’s disease has several distinguishing characteristics:…
CDC focused on finding ‘nightmare bacteria’ and preventing their spread

CDC focused on finding ‘nightmare bacteria’ and preventing their spread

Dr. Kelly Arps The Centers for Disease Control and Prevention communicated on Tuesday the early outcomes of their targeted campaign to identify infections…
Stem cell trial aims to cure blindness

Stem cell trial aims to cure blindness

Surgeons in London have carried out a pioneering human embryonic stem cell operation in an ongoing trial to find a cure for blindness for many patients.…
Parkinson’s disease

Parkinson’s disease

Parkinson’s disease (PD) is a neurodegenerative brain disorder that progresses slowly in most people. What this means is that individuals with PD…
Parkinson’s disease: cause and effect

Parkinson’s disease: cause and effect

Parkinson’s Disease is a gradually progressive disorder of the nervous system that causes mainly a loss of motor skills. It usually affects people…
10 early signs of parkinson’s disease

10 early signs of parkinson’s disease

It can be hard to tell if you or a loved one has Parkinson's disease (PD). Below are 10 signs that you might have the disease. No single one of these…
Hand & microsurgery hand injuries and treatments

Hand & microsurgery hand injuries and treatments

The hands are one of the most important parts of human body. Hands are very complex organ with multiple joints, different types of ligaments, tendons…
Universal health care in Bangladesh—promises and perils

Universal health care in Bangladesh—promises and perils

Valid and reliable indicators against which progress towards global targets of 80% coverage of health services and 100% financial protection from catastrophic…
The devastating side effects of antidepressants

The devastating side effects of antidepressants

Jessica Wick Anxiety and depression are all too common in our society — and no one is exempt. Even some of our most well-known celebrities have…
Occupational therapy for parkinson’s disease

Occupational therapy for parkinson’s disease

Parkinson’s is a chronic, insidiously progressing, neurological condition. The most common clinical features are believed to result from the progressive…
IPNA becomes first ever institute in BSMMU

IPNA becomes first ever institute in BSMMU

University Grant Commission (UGC) has approved “Establishment of Institute of Paediatric Neurodisorder and Autism (IPNA)” as full-fledged,…
More than half your body is not human

More than half your body is not human

James Gallagher More than half of your body is not human, say scientists. Human cells make up only 43% of the body's total cell count. The rest are…
FDA approves ZTlido

FDA approves ZTlido

Sorrento Therapeutics Subsidiary, Scilex, receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting